Mendus receives U.S. FDA Fast Track Designation for vididenc

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that it has received Fast Track Designation from the U.S. Food and Drug Administration ...

Related Keywords

United States , Stockholm , Sweden , Netherlands , American , Corey Davis , Mario Brkulj , Erik Manting , American Society Of Hematology , Valency Communications , Drug Administration , Lifesci Advisors , European Medicines Agency , Fast Track Designation , Acute Myeloid Leukemia , Orphan Drug Designation , Advanced Therapy Medicinal Product , Jeroen Rovers , Chief Medical Officer , American Society , Nasdaq Stockholm , Sci Advisors , Markets ,